Syneika offers therapeutic solutions to relieve chronic neurological and psychiatric diseases using a neurostimulation technique: Transcranial Magnetic Stimulation TMS. Transcranial Magnetic Stimulation TMS interacts with the electrical activity of neurons in a non-invasive and painless way: high intensity electromagnetic pulses applied to specific areas of the brain thus relieve lasting symptoms. The main indications of Transcranial Magnetic Stimulation TMS are the treatment of chronic pain, especially neuropathic, as well as the treatment of major depressive episode.
A positive effect can also be observed in post-Stroke motor rehabilitation, Obsessive-Compulsive Disorders, Alzheimer’s Disease or Parkinson’s Disease.
Convinced that the highest quality TMS should be accessible to anyone, Syneika developed Syneika ONE neuronavigation, MRI based guidance equipment, which allows any operator to perform individualized TMS, even being far from a University hospital, and contribute to productivity of TMS.
Syneika has established and applies a quality management system that fulfills the requirements specified in EN ISO 13485:2003+AC:2009.
Company’s Keywords:
imageguided medicine, neurostimulation, pain management, major depression
<9
<
<2009